VAERS reports by lot

Pfizer COVID-19 lot HF9300: VAERS reports

120 VAERS reports list lot HF9300 as a Pfizer COVID-19 vaccine, received between 2023-10-21 and 2024-12-27. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
120
Reports
2%
Marked serious
0
With a death outcome
10
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction2920%
Cardiac / Cardiovascular2518%
General / Systemic (non-local)2215%
Neurological1712%
Musculoskeletal1611%
Dermatological (non-injection-site)107%
Gastrointestinal96%
Respiratory75%
Psychiatric / Neuropsychiatric43%
Allergic / Anaphylactic32%

Where reports came from

U.S. state of the reporter, where given (top 12).

California13
Texas5
Indiana3
Colorado2
Oregon2
Oklahoma2
Kentucky2
New Hampshire2
Wisconsin2
Minnesota2
Michigan2
Alabama1

Reports by month received

2023-109
2023-1116
2023-1211
2024-0111
2024-022
2024-034
2024-0562
2024-063
2024-091
2024-121

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.